The receptor tyrosine kinase inhibitor vandetanib activates Akt and increases side population in a salivary gland tumor cell line (A253)

Author:            

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.41, Iss.1, 2012-01, pp. : 362-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content